Delivery Order SPE2DB24D1104-SPE2DB25FXWR4
Award Date
1/21/25
Potential Completion Date
1/22/25
Potential Value
$6.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $6,081.82. The contract is a firm fixed-price delivery order and is not set-aside. The period of performance extends through May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $5,241.50 and an ultimate completion date of May 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, at a firm fixed price of $6,693.65. The contract has a period of performance ending on May 22, 2025. This delivery order is not set aside for any special program. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $8,018.42 and a period of performance through March 27, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $18,333.85. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of July 26, 2024. This contract award is not designated with a set-aside requirement....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product. The contract has a ceiling value of $7,010.65 and a performance period ending on April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $4,037.20 and a performance period through June 6, 2025. The contract is not set aside for any special designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,196.60, is for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUROLANE 60 MG/3 ML SYRINGE 3ML, a medical product, with a ceiling value of $3,506.69 and a performance period ending on March 24, 2025. The contract is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of DUROLANE 60 MG/3 ML SYRINGE 3ML medical products. The contract is a Delivery Order with a Firm Fixed Price type, valued at $6,650.13, and has an ultimate completion date of November 6, 2024. This award is not associated with a specific set-aside program. Amerisourcebergen holds a significant Indefinite...